These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect. Yang Y; Chen G; Cheng X; Teng Z; Cai X; Yang J; Sun X; Lu W; Wang X; Yao Y; Hu C; Cao P Sci Rep; 2015 Jul; 5():12377. PubMed ID: 26205695 [TBL] [Abstract][Full Text] [Related]
3. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling. Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101 [TBL] [Abstract][Full Text] [Related]
4. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Jiang T; Huang Z; Lin Y; Zhang Z; Fang D; Zhang DD Diabetes; 2010 Apr; 59(4):850-60. PubMed ID: 20103708 [TBL] [Abstract][Full Text] [Related]
5. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678 [TBL] [Abstract][Full Text] [Related]
6. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells. Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797 [TBL] [Abstract][Full Text] [Related]
7. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function. Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670 [TBL] [Abstract][Full Text] [Related]
8. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway. Xie Z; Zhong L; Wu Y; Wan X; Yang H; Xu X; Li P Phytomedicine; 2018 Aug; 47():161-173. PubMed ID: 30166101 [TBL] [Abstract][Full Text] [Related]
10. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149 [TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635 [TBL] [Abstract][Full Text] [Related]
12. CKIP-1 ameliorates high glucose-induced expression of fibronectin and intercellular cell adhesion molecule-1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Gong W; Chen C; Xiong F; Yang Z; Wang Y; Huang J; Liu P; Huang H Biochem Pharmacol; 2016 Sep; 116():140-52. PubMed ID: 27481061 [TBL] [Abstract][Full Text] [Related]
13. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation. Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771 [TBL] [Abstract][Full Text] [Related]
14. Connexin43 regulates high glucose-induced expression of fibronectin, ICAM-1 and TGF-β1 via Nrf2/ARE pathway in glomerular mesangial cells. Chen Z; Xie X; Huang J; Gong W; Zhu X; Chen Q; Huang J; Huang H Free Radic Biol Med; 2017 Jan; 102():77-86. PubMed ID: 27840317 [TBL] [Abstract][Full Text] [Related]
15. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443 [TBL] [Abstract][Full Text] [Related]
16. Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation. Cui W; Bai Y; Miao X; Luo P; Chen Q; Tan Y; Rane MJ; Miao L; Cai L Oxid Med Cell Longev; 2012; 2012():821936. PubMed ID: 23050040 [TBL] [Abstract][Full Text] [Related]
17. Artemisinin attenuates early renal damage on diabetic nephropathy rats through suppressing TGF-β1 regulator and activating the Nrf2 signaling pathway. Zhang H; Qi S; Song Y; Ling C Life Sci; 2020 Sep; 256():117966. PubMed ID: 32535079 [TBL] [Abstract][Full Text] [Related]
18. Nrf2 activators as attractive therapeutics for diabetic nephropathy. de Haan JB Diabetes; 2011 Nov; 60(11):2683-4. PubMed ID: 22025774 [No Abstract] [Full Text] [Related]
19. Salvia miltiorrhiza Lipophilic Fraction Attenuates Oxidative Stress in Diabetic Nephropathy through Activation of Nuclear Factor Erythroid 2-Related Factor 2. An L; Zhou M; Marikar FMMT; Hu XW; Miao QY; Li P; Chen J Am J Chin Med; 2017; 45(7):1441-1457. PubMed ID: 28946766 [TBL] [Abstract][Full Text] [Related]
20. Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response. Jiang T; Tian F; Zheng H; Whitman SA; Lin Y; Zhang Z; Zhang N; Zhang DD Kidney Int; 2014 Feb; 85(2):333-343. PubMed ID: 24025640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]